Answers are grounded in this paper and cite their sources.
Pilot study shows nuanced gait changes in preclinical pancreatic cancer model, suggesting early impairment.
Cancer cachexia (CC) is a multifactorial metabolic syndrome characterized by progressive skeletal muscle wasting, functional decline, and reduced survival. Gait speed and spatiotemporal gait parameters are being considered as clinical biomarkers of frailty, mobility impairment, and physiological reserve across cancer populations. However, whether gait mechanics change prior to phenotypic loss in preclinical cachexia models is unclear. We hypothesized alterations to gait mechanics would begin prior to onset of phenotypic cachexia in a preclinical model of pancreatic CC. METHODS: C57BL/6J mice (12 weeks old, male) were used to evaluate longitudinal gait changes during the development of pancreatic cancer induced cachexia. Orthotopic tumors were induced by injecting 150,000 KPC-FC1245 cells into the pancreas of cancer groups (KPC), healthy controls received a sham injection of Phosphate Buffered Saline (PBS) to the pancreas. Gait mechanics were assessed prior to tumor implantation (baseline), before onset of CC (12 days post tumor implantation) and at CC (19 days post tumor implantation) timepoints using the Noldus CatWalk XT automated gait analysis system, to quantify gait parameters including gait speed, stride length, stand duration, and cadence. Gait recordings were performed under controlled lighting, walkway calibration, and standardized run acceptance criteria to minimize variability. Data were analyzed using 2X3 ANOVAs between experimental groups (PBS v KPC) repeated across timepoints, with alpha set at .05. RESULTS: A timepoint main effect in forelimb stride length approached significance (p= .07), with progressive reductions suggesting emerging impairment in forward propulsion as disease advanced. Similarly, a Group*Timepoint interaction for forelimb body speed exhibited also approached significance(p= .065), suggesting cancer-specific compensatory modulation of forelimb movement across cachexia progression. Hindlimb duty cycle, the fraction of the gait cycle when the hindlimb contacts the ground, appeared to decline over Time (p= .056), suggesting shortened stance duration and potential hindlimb unloading in KPC mice. Hindlimb base of support (BOS) displayed a near significant Group*Timepoint interaction (p= .057), with KPC mice widening BOS during pre-cachexia before narrowing in full cachexia; a postural adjustment not observed in controls. Additionally, cadence differed by Group (p< .05), indicating a distinct stepping rhythm induced by pancreatic cancer independent of overall walking speed. CONCLUSION: These preliminary findings suggest KPC mice develop potentially subtle, yet functionally significant, gait changes during cachexia development, including shorter forelimb strides, altered speed modulation, reduced hindlimb stability, postural adjustments, and increased stepping cadence. These findings may be used to provide direct comparison for gait alterations between preclinical and clinical cancer studies. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
Noga et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: